Notas do episódio
GLP-1 drugs such as Ozempic have become some of the world's most-wanted medicines, but soaring demand has also turned them into a stress test for the global drug system.
On this episode of Why It Matters, we trace how the GLP-1 trend led to shortages, a booming gray market, and steep price gaps driven by patent laws that vary across borders.
Host:
Gabrielle Sierra, Director of Podcasting, Council on Foreign Relations (CFR)
Guest:
Prashant Yadav, Senior Fellow for Global Health, Council on Foreign Relations (CFR)
Read More:
“6 Facts About Obesity and Weight Loss Drugs In the U.S.,” Pew…
Site: cfrwhyitmatters.podbean.com

